Compartir
Título
Exposure to Morphine and Cocaine Modify the Transcriptomic Landscape in Zebrafish Embryos
Autor(es)
Palabras clave
Transcriptomic assay
Morphine
Cocaine
DNA methylation
Zebrafish
Clasificación UNESCO
2415 Biología Molecular
Fecha de publicación
2022
Editor
Elsevier
Citación
Calderon-Garcia, A. A., Perez-Fernandez, M., Curto-Aguilera, D., Rodriguez-Martin, I., Sánchez-Barba, M., & Gonzalez-Nunez, V. (2022). Exposure to Morphine and Cocaine Modify the Transcriptomic Landscape in Zebrafish Embryos. Neuroscience, 507, 14-27. https://doi.org/10.1016/j.neuroscience.2022.10.017
Resumen
[EN]Morphine and other opioid analgesics are the drugs of election to treat moderate-to-severe pain, and
they elicit their actions by binding to the opioid receptors. Cocaine is a potent inhibitor of dopamine, serotonin,
and noradrenaline reuptake, as it blocks DAT, the dopamine transporter, causing an increase in the local concentration of these neurotransmitters in the synaptic cleft. The molecular effects of these drugs have been studied in
specific brain areas or nuclei, but the systemic effects in the whole organism have not been comprehensively analyzed. This study aims to analyze the transcriptomic changes elicited by morphine (10 uM) and cocaine (15 uM) in
zebrafish embryos. An RNAseq assay was performed with tissues extracts from zebrafish embryos treated from
5 hpf (hours post fertilization) to 72 hpf, and the most representative deregulated genes were experimentally validated by qPCR. We have found changes in the expression of genes related to lipid metabolism, chemokine receptor ligands, visual system, hemoglobins, and metabolic detoxification pathways. Besides, morphine and cocaine
modified the global DNA methylation pattern in zebrafish embryos, which would explain the changes in gene
expression elicited by these two drugs of abuse.
URI
ISSN
0306-4522
DOI
10.1016/j.neuroscience.2022.10.017
Versión del editor
Collections
Patrocinador
Publicación en abierto financiada por la Universidad de Salamanca como participante en el Acuerdo Transformativo CRUE-CSIC con Elsevier, 2021-2024













